Report Detail

Pharma & Healthcare Global Pediatric Gastrointestinal Drugs Market Research Report 2022

  • RnM4454743
  • |
  • 17 June, 2022
  • |
  • Global
  • |
  • 96 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Industry Insights
The global Pediatric Gastrointestinal Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Tablets accounting for % of the Pediatric Gastrointestinal Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.

China Pediatric Gastrointestinal Drugs market size is valued at US$ million in 2021, while the North America and Europe Pediatric Gastrointestinal Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pediatric Gastrointestinal Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediatric Gastrointestinal Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediatric Gastrointestinal Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediatric Gastrointestinal Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediatric Gastrointestinal Drugs market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Pediatric Gastrointestinal Drugs market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Pediatric Gastrointestinal Drugs Breakdown Data by Type

Tablets

Pills

Oral Liquid

Pediatric Gastrointestinal Drugs Breakdown Data by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Regional Analysis

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

AstraZeneca

Sanofi

Aptalis

Eisai

Pfizer

Zeria (Tillotts)

GlaxoSmithKline

Salix Pharmaceuticals

Perrigo

Abbott

Honz Pharmaceutical

Shandong DYNE Marine Biopharmaceutical

Sunflower Pharmaceutical

Jiangzhong Pharmaceutical

Yabao Pharmaceutical

Jumpcan Pharmaceutical

Hansen Pharmaceutical

Frequently Asked Questions

What factors will challenge the Pediatric Gastrointestinal Drugs market growth?

Which end-use segment will expand at the fastest CAGR in the Pediatric Gastrointestinal Drugs market?

Which are the emerging players in the Pediatric Gastrointestinal Drugs market?

How concentrated is the Pediatric Gastrointestinal Drugs market?

Which factors are positively contributing to the Pediatric Gastrointestinal Drugs market growth?

Which are the novel product innovations in the Pediatric Gastrointestinal Drugs market?

Which product segment will emerge as the most lucrative in the Pediatric Gastrointestinal Drugs market?

Which factors are increasing the competition in the Pediatric Gastrointestinal Drugs market?

Which are the strategic measures taken by the Pediatric Gastrointestinal Drugs industry players?

Which region will witness inactive growth during the forecast period?

What key trends are likely to emerge in the Pediatric Gastrointestinal Drugs market in the coming years?


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
  • 1.2.1 Global Pediatric Gastrointestinal Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
  • 1.2.2 Tablets
  • 1.2.3 Pills
  • 1.2.4 Oral Liquid
  • 1.3 Market by Application
  • 1.3.1 Global Pediatric Gastrointestinal Drugs Market Share by Application: 2017 VS 2021 VS 2028
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Online Pharmacies
  • 1.3.4 Retail Pharmacies
  • 1.4 Study Objectives
  • 1.5 Years Considered
  • 2 Global Growth Trends

    • 2.1 Global Pediatric Gastrointestinal Drugs Market Perspective (2017-2028)
    • 2.2 Pediatric Gastrointestinal Drugs Growth Trends by Region
    • 2.2.1 Pediatric Gastrointestinal Drugs Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Pediatric Gastrointestinal Drugs Historic Market Size by Region (2017-2022)
  • 2.2.3 Pediatric Gastrointestinal Drugs Forecasted Market Size by Region (2023-2028)
  • 2.3 Pediatric Gastrointestinal Drugs Market Dynamics
  • 2.3.1 Pediatric Gastrointestinal Drugs Industry Trends
  • 2.3.2 Pediatric Gastrointestinal Drugs Market Drivers
  • 2.3.3 Pediatric Gastrointestinal Drugs Market Challenges
  • 2.3.4 Pediatric Gastrointestinal Drugs Market Restraints
  • 3 Competition Landscape by Key Players

    • 3.1 Global Top Pediatric Gastrointestinal Drugs Players by Revenue
    • 3.1.1 Global Top Pediatric Gastrointestinal Drugs Players by Revenue (2017-2022)
  • 3.1.2 Global Pediatric Gastrointestinal Drugs Revenue Market Share by Players (2017-2022)
  • 3.2 Global Pediatric Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Pediatric Gastrointestinal Drugs Revenue
  • 3.4 Global Pediatric Gastrointestinal Drugs Market Concentration Ratio
  • 3.4.1 Global Pediatric Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Pediatric Gastrointestinal Drugs Revenue in 2021
  • 3.5 Pediatric Gastrointestinal Drugs Key Players Head office and Area Served
  • 3.6 Key Players Pediatric Gastrointestinal Drugs Product Solution and Service
  • 3.7 Date of Enter into Pediatric Gastrointestinal Drugs Market
  • 3.8 Mergers & Acquisitions, Expansion Plans
  • 4 Pediatric Gastrointestinal Drugs Breakdown Data by Type

    • 4.1 Global Pediatric Gastrointestinal Drugs Historic Market Size by Type (2017-2022)
    • 4.2 Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Type (2023-2028)

    5 Pediatric Gastrointestinal Drugs Breakdown Data by Application

    • 5.1 Global Pediatric Gastrointestinal Drugs Historic Market Size by Application (2017-2022)
    • 5.2 Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America Pediatric Gastrointestinal Drugs Market Size (2017-2028)
    • 6.2 North America Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022)
    • 6.3 North America Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028)
    • 6.4 United States
    • 6.5 Canada

    7 Europe

    • 7.1 Europe Pediatric Gastrointestinal Drugs Market Size (2017-2028)
    • 7.2 Europe Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022)
    • 7.3 Europe Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028)
    • 7.4 Germany
    • 7.5 France
    • 7.6 U.K.
    • 7.7 Italy
    • 7.8 Russia
    • 7.9 Nordic Countries

    8 Asia-Pacific

    • 8.1 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size (2017-2028)
    • 8.2 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022)
    • 8.3 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028)
    • 8.4 China
    • 8.5 Japan
    • 8.6 South Korea
    • 8.7 Southeast Asia
    • 8.8 India
    • 8.9 Australia

    9 Latin America

    • 9.1 Latin America Pediatric Gastrointestinal Drugs Market Size (2017-2028)
    • 9.2 Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022)
    • 9.3 Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028)
    • 9.4 Mexico
    • 9.5 Brazil

    10 Middle East & Africa

    • 10.1 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size (2017-2028)
    • 10.2 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022)
    • 10.3 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028)
    • 10.4 Turkey
    • 10.5 Saudi Arabia
    • 10.6 UAE

    11 Key Players Profiles

    • 11.1 AstraZeneca
    • 11.1.1 AstraZeneca Company Detail
  • 11.1.2 AstraZeneca Business Overview
  • 11.1.3 AstraZeneca Pediatric Gastrointestinal Drugs Introduction
  • 11.1.4 AstraZeneca Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.1.5 AstraZeneca Recent Development
  • 11.2 Sanofi
  • 11.2.1 Sanofi Company Detail
  • 11.2.2 Sanofi Business Overview
  • 11.2.3 Sanofi Pediatric Gastrointestinal Drugs Introduction
  • 11.2.4 Sanofi Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.2.5 Sanofi Recent Development
  • 11.3 Aptalis
  • 11.3.1 Aptalis Company Detail
  • 11.3.2 Aptalis Business Overview
  • 11.3.3 Aptalis Pediatric Gastrointestinal Drugs Introduction
  • 11.3.4 Aptalis Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.3.5 Aptalis Recent Development
  • 11.4 Eisai
  • 11.4.1 Eisai Company Detail
  • 11.4.2 Eisai Business Overview
  • 11.4.3 Eisai Pediatric Gastrointestinal Drugs Introduction
  • 11.4.4 Eisai Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.4.5 Eisai Recent Development
  • 11.5 Pfizer
  • 11.5.1 Pfizer Company Detail
  • 11.5.2 Pfizer Business Overview
  • 11.5.3 Pfizer Pediatric Gastrointestinal Drugs Introduction
  • 11.5.4 Pfizer Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.5.5 Pfizer Recent Development
  • 11.6 Zeria (Tillotts)
  • 11.6.1 Zeria (Tillotts) Company Detail
  • 11.6.2 Zeria (Tillotts) Business Overview
  • 11.6.3 Zeria (Tillotts) Pediatric Gastrointestinal Drugs Introduction
  • 11.6.4 Zeria (Tillotts) Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.6.5 Zeria (Tillotts) Recent Development
  • 11.7 GlaxoSmithKline
  • 11.7.1 GlaxoSmithKline Company Detail
  • 11.7.2 GlaxoSmithKline Business Overview
  • 11.7.3 GlaxoSmithKline Pediatric Gastrointestinal Drugs Introduction
  • 11.7.4 GlaxoSmithKline Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.7.5 GlaxoSmithKline Recent Development
  • 11.8 Salix Pharmaceuticals
  • 11.8.1 Salix Pharmaceuticals Company Detail
  • 11.8.2 Salix Pharmaceuticals Business Overview
  • 11.8.3 Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Introduction
  • 11.8.4 Salix Pharmaceuticals Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.8.5 Salix Pharmaceuticals Recent Development
  • 11.9 Perrigo
  • 11.9.1 Perrigo Company Detail
  • 11.9.2 Perrigo Business Overview
  • 11.9.3 Perrigo Pediatric Gastrointestinal Drugs Introduction
  • 11.9.4 Perrigo Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.9.5 Perrigo Recent Development
  • 11.10 Abbott
  • 11.10.1 Abbott Company Detail
  • 11.10.2 Abbott Business Overview
  • 11.10.3 Abbott Pediatric Gastrointestinal Drugs Introduction
  • 11.10.4 Abbott Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.10.5 Abbott Recent Development
  • 11.11 Honz Pharmaceutical
  • 11.11.1 Honz Pharmaceutical Company Detail
  • 11.11.2 Honz Pharmaceutical Business Overview
  • 11.11.3 Honz Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
  • 11.11.4 Honz Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.11.5 Honz Pharmaceutical Recent Development
  • 11.12 Shandong DYNE Marine Biopharmaceutical
  • 11.12.1 Shandong DYNE Marine Biopharmaceutical Company Detail
  • 11.12.2 Shandong DYNE Marine Biopharmaceutical Business Overview
  • 11.12.3 Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Introduction
  • 11.12.4 Shandong DYNE Marine Biopharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.12.5 Shandong DYNE Marine Biopharmaceutical Recent Development
  • 11.13 Sunflower Pharmaceutical
  • 11.13.1 Sunflower Pharmaceutical Company Detail
  • 11.13.2 Sunflower Pharmaceutical Business Overview
  • 11.13.3 Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
  • 11.13.4 Sunflower Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.13.5 Sunflower Pharmaceutical Recent Development
  • 11.14 Jiangzhong Pharmaceutical
  • 11.14.1 Jiangzhong Pharmaceutical Company Detail
  • 11.14.2 Jiangzhong Pharmaceutical Business Overview
  • 11.14.3 Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
  • 11.14.4 Jiangzhong Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.14.5 Jiangzhong Pharmaceutical Recent Development
  • 11.15 Yabao Pharmaceutical
  • 11.15.1 Yabao Pharmaceutical Company Detail
  • 11.15.2 Yabao Pharmaceutical Business Overview
  • 11.15.3 Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
  • 11.15.4 Yabao Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.15.5 Yabao Pharmaceutical Recent Development
  • 11.16 Jumpcan Pharmaceutical
  • 11.16.1 Jumpcan Pharmaceutical Company Detail
  • 11.16.2 Jumpcan Pharmaceutical Business Overview
  • 11.16.3 Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
  • 11.16.4 Jumpcan Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.16.5 Jumpcan Pharmaceutical Recent Development
  • 11.17 Hansen Pharmaceutical
  • 11.17.1 Hansen Pharmaceutical Company Detail
  • 11.17.2 Hansen Pharmaceutical Business Overview
  • 11.17.3 Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
  • 11.17.4 Hansen Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022)
  • 11.17.5 Hansen Pharmaceutical Recent Development
  • 12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
    • 13.2 Disclaimer
    • Summary:
      Get latest Market Research Reports on Pediatric Gastrointestinal Drugs. Industry analysis & Market Report on Pediatric Gastrointestinal Drugs is a syndicated market report, published as Global Pediatric Gastrointestinal Drugs Market Research Report 2022. It is complete Research Study and Industry Analysis of Pediatric Gastrointestinal Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,404.10
      4,808.20
      2,781.10
      5,562.20
      392,921.00
      785,842.00
      229,042.00
      458,084.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report